Literature DB >> 7296345

Differential distribution of sphingomyelins among plasma lipoprotein classes.

J J Myher, A Kuksis, W C Breckenridge, J A Little.   

Abstract

Individual and pooled samples of plasma from normolipemic and hyperlipemic subjects were separated into very low density lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein fractions (HDL2 and HDL3) by conventional ultracentrifugation and total lipid extracts prepared by standard methods. The composition of the molecular species of the sphingomyelins in each lipoprotein class was determined by packed column and capillary gas-liquid chromatography of the trimethylsilyl (TMS) and t-butyldimethylsilyl (t-BDMS) ethers and by gas chromatography - mass spectrometry of t-BDMS ethers of ceramides derived by phospholipase C hydrolysis of the corresponding parent compounds. It was demonstrated that the molecular weight of the species of the sphingomyelins increases with the density of the lipoprotein fraction in normolipemic subjects, and that this increase is due to an increase in the chain length of the fatty acids in the ceramide molecules. In contrast, patients with type IV hyperlipoproteinemia possessed similar species in the LDL and HDL fractions, while maintaining normal differences between HDL and VLDL. Type III patients possessed normal HDL and VLDL differences, but had variable LDL. Type II patients had ceramide profiles for VLDL, LDL, and HDL fractions that were very similar to those of normals. The differential distribution of the molecular species of the sphingomyelins is rationalized on the basis of a lateral phase separation of the short and long chain sphingomyelins during the shedding of the excess VLDL or chylomicron surface material and a subsequent preferential transformation of the long chain species into HDL. The LDL sphingomyelins in type III hyperlipemia are variable and approximate either the VLDL or HDL composition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296345     DOI: 10.1139/o81-087

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  7 in total

Review 1.  HDL lipids and insulin resistance.

Authors:  Andrew N Hoofnagle; Tomas Vaisar; Poulami Mitra; Alan Chait
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

2.  Tamoxifen-induced modification of serum lipoprotein phospholipids in the cockerel.

Authors:  W C Breckenridge; C B Lazier
Journal:  Lipids       Date:  1987-07       Impact factor: 1.880

3.  Distribution of the molecular species of phospholipids in human umbilical cord blood.

Authors:  W C Breckenridge; P J Dolphin; M H Tan
Journal:  Lipids       Date:  1984-05       Impact factor: 1.880

4.  Molecular species of glycerophospholipids and sphingomyelins of human plasma: comparison to red blood cells.

Authors:  J J Myher; A Kuksis; S Pind
Journal:  Lipids       Date:  1989-05       Impact factor: 1.880

5.  Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: improved method of analysis.

Authors:  J J Myher; A Kuksis; S Pind
Journal:  Lipids       Date:  1989-05       Impact factor: 1.880

6.  Association of ceramides in human plasma with risk factors of atherosclerosis.

Authors:  Ikuyo Ichi; Kayoko Nakahara; Yayoi Miyashita; Atsuko Hidaka; Sahoko Kutsukake; Kana Inoue; Taro Maruyama; Yoshikazu Miwa; Mariko Harada-Shiba; Motoo Tsushima; Shosuke Kojo
Journal:  Lipids       Date:  2006-09       Impact factor: 1.646

Review 7.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.